Purchase Order 75F40120P00214
Award Date 5/20/20
Potential Completion Date 5/20/25
Potential Value $113K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Pharmaceutical Press LIMITED, a not-for-profit organization located in the United Kingdom. The contract is for an online subscription to the Handbook of Pharmaceutical Excipients, with a firm fixed price of $15,150.00 and a completion date of June 30, 2015. The contract does not have a set-aside designation. No subcontractors are mentioned. The FDA is responsible for regulating...
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm fixed-price purchase order contract to Elsevier B.V., doing business as North-Holland (Publishing), for a PharmacoKinetic and Metabolizing Enzyme Modules subscription. The contract has a potential value of $529,066.01 and a completion date of September 29, 2021. The contract provides the FDA Library with unlimited online access to Elsevier's databases, including drug safety and efficacy data, to support...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $40,143 purchase order contract to Proquest LLC for access to its legislative and regulatory insight collection for the years 2023 through 2024. Under the firm fixed price contract, Proquest will provide its database of materials tracking laws, regulations, and policies pertinent to HHS FDA programs and operations. No subcontractors or set aside designations were specified. The collection will support...
- This firm fixed-price contract was awarded to Prenax Inc. by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) on December 9, 2019. The contract, valued at $170,985.84, is a BPA Call order under Prenax's existing General Services Administration (GSA) Publication Media Schedule contract. The contract is for the delivery of subscription-based resources and publications management services, including visibility and control, cost optimization, vendor...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Informa Business Intelligence, Inc., a leading business intelligence, academic publishing, and events company. The contract, valued at $558,929.41, is for the provision of specialized information services and resources, including subscriptions to databases and platforms such as PharmaProjects, Pink Sheet, TrialTrove, and Medtrack, which provide...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order valued at one hundred twenty thousand, six hundred thirty-eight dollars ($120,638) to Politico, LLC, a foreign owned, self-certified small disadvantaged business and for-profit organization. The award, which does not have a set-aside designation, is for an online Politico Pro subscription to provide legislative tracking, notices of hearings and transcripts, and other relevant...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to Informa Business Intelligence, Inc., a foreign-owned for-profit organization, for a "TRIALTROVE" online subscription with one option year. The contract is valued at $145,951.00 and does not have a small business set-aside designation. The subscription provides the FDA's Office of Clinical Pharmacology Genomics Group access to clinical trial protocol data and biomarker...
- This is a $18,230.00 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to The United States Pharmacopeial Convention, Inc. (USP). The contract is for an online subscription to USP's products, which include the United States Pharmacopeia National Formulary, Food Chemicals Codex, and USP Dictionary of Adopted Names. USP is an independent, scientific non-profit organization that sets standards for the identity, quality, and safety of medicines, food...
- This delivery order, awarded by the Department of Health and Human Services' Food and Drug Administration, is for $240,000 worth of pharmaceutical products to support domestic manufacturing and regulatory purposes. We Pharma, Inc. will provide the products in Takoma Park, Maryland by September 30, 2023 under a firm fixed price arrangement. As the FDA works to ensure the safety and effectiveness of drugs and medical devices, this contract will help the agency assess pharmaceutical manufacturing...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Health and Human Services (DHHS) Food and Drug Administration (FDA) to Prenax Inc., a for-profit organization that specializes in outsourced procurement and management of subscription-based resources. The potential value of the contract is $144,947.00. The contract is under the Publication Media (FSS-76) schedule of the General Services Administration (GSA). The contract is for the provision of...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to The Pharma Letter LIMITED, a for-profit organization, for a $113,008.00 pharmaceutical subscription for 25 users. The contract has a performance period ending May 20, 2025, with an award date of May 20, 2020. The subscription provides the FDA's Office of Global Policy and Strategy (OGPS) staff with access to global news, expert commentary, and analysis on pharmaceutical, generic, and biotechnology topics to support the FDA's medical products portfolio. The contract was a competitive procurement with no set-aside requirement.
Generated 4/26/24, 11:21 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmacetical Subscription | FDA-20-RFQ-1222268 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/2 | 1/23/20, 9:33 AM | |
Pharmacetical Subscription | FDA-20-RFQ-1222268 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Award Notice 2/2 | 5/20/20, 2:14 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Exercise an Option | $24.9k | 4/24/24 | |
| P00004 | Exercise an Option | $23.7k | 3/20/23 | |
| P00003 | Other Administrative Action | $0 | 4/21/22 | |
| P00002 | Exercise an Option | $22.5k | 2/13/22 | |
| P00001 | Exercise an Option | $21.5k | 4/14/21 |